Ownership history in ARMISTICE CAPITAL, LLC · 16 quarters on record
This page tracks every 13F SEC filing in which ARMISTICE CAPITAL, LLC reported a position in AGIOS PHARMACEUTICALS INC (AGIO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 3,000,000 | -36,000 | -1.2% | 0.97% | $81.7M | $27.22 |
| 2025 Q4 | ADDED | 3,036,000 | +2,136,000 | +237.3% | 0.98% | $82.6M | $27.22 |
| 2025 Q3 | ADDED | 900,000 | +136,000 | +17.8% | 0.54% | $36.1M | $40.14 |
| 2025 Q3 | REDUCED | 764,000 | -404,000 | -34.6% | 0.45% | $30.7M | $40.14 |
As of 2025 Q4 — sorted by position size